These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 31628391)

  • 1. Acceleration in the DNA methylation age in breast cancer tumours from very young women.
    Oltra SS; Peña-Chilet M; Flower K; Martinez MT; Alonso E; Burgues O; Lluch A; Flanagan JM; Ribas G
    Sci Rep; 2019 Oct; 9(1):14991. PubMed ID: 31628391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methylation deregulation of miRNA promoters identifies miR124-2 as a survival biomarker in Breast Cancer in very young women.
    Oltra SS; Peña-Chilet M; Vidal-Tomas V; Flower K; Martinez MT; Alonso E; Burgues O; Lluch A; Flanagan JM; Ribas G
    Sci Rep; 2018 Sep; 8(1):14373. PubMed ID: 30258192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An integrated genomics analysis of epigenetic subtypes in human breast tumors links DNA methylation patterns to chromatin states in normal mammary cells.
    Holm K; Staaf J; Lauss M; Aine M; Lindgren D; Bendahl PO; Vallon-Christersson J; Barkardottir RB; Höglund M; Borg Å; Jönsson G; Ringnér M
    Breast Cancer Res; 2016 Feb; 18(1):27. PubMed ID: 26923702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring breast carcinogenesis through integrative genomics and epigenomics analyses.
    Minning C; Mokhtar NM; Abdullah N; Muhammad R; Emran NA; Ali SA; Harun R; Jamal R
    Int J Oncol; 2014 Nov; 45(5):1959-68. PubMed ID: 25175708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic and genetic burden measures are associated with tumor characteristics in invasive breast carcinoma.
    O'Sullivan DE; Johnson KC; Skinner L; Koestler DC; Christensen BC
    Epigenetics; 2016 May; 11(5):344-53. PubMed ID: 27070496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA methylation across the genome in aged human skeletal muscle tissue and muscle-derived cells: the role of HOX genes and physical activity.
    Turner DC; Gorski PP; Maasar MF; Seaborne RA; Baumert P; Brown AD; Kitchen MO; Erskine RM; Dos-Remedios I; Voisin S; Eynon N; Sultanov RI; Borisov OV; Larin AK; Semenova EA; Popov DV; Generozov EV; Stewart CE; Drust B; Owens DJ; Ahmetov II; Sharples AP
    Sci Rep; 2020 Sep; 10(1):15360. PubMed ID: 32958812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic Changes of the ESR1 Gene in Breast Tissue of Healthy Women: A Missing Link with Breast Cancer Risk Factors?
    Daraei A; Izadi P; Khorasani G; Nafissi N; Naghizadeh MM; Younosi N; Meysamie A; Mansoori Y; Bastami M; Tavakkoly-Bazzaz J
    Genet Test Mol Biomarkers; 2017 Aug; 21(8):464-470. PubMed ID: 28708432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic regulation of cancer stem cell genes in triple-negative breast cancer.
    Kagara N; Huynh KT; Kuo C; Okano H; Sim MS; Elashoff D; Chong K; Giuliano AE; Hoon DS
    Am J Pathol; 2012 Jul; 181(1):257-67. PubMed ID: 22626806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA methylation of GHSR, GNG4, HOXD9 and SALL3 is a common epigenetic alteration in thymic carcinoma.
    Kishibuchi R; Kondo K; Soejima S; Tsuboi M; Kajiura K; Kawakami Y; Kawakita N; Sawada T; Toba H; Yoshida M; Takizawa H; Tangoku A
    Int J Oncol; 2020 Jan; 56(1):315-326. PubMed ID: 31746370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA methylome analysis identifies accelerated epigenetic ageing associated with postmenopausal breast cancer susceptibility.
    Ambatipudi S; Horvath S; Perrier F; Cuenin C; Hernandez-Vargas H; Le Calvez-Kelm F; Durand G; Byrnes G; Ferrari P; Bouaoun L; Sklias A; Chajes V; Overvad K; Severi G; Baglietto L; Clavel-Chapelon F; Kaaks R; Barrdahl M; Boeing H; Trichopoulou A; Lagiou P; Naska A; Masala G; Agnoli C; Polidoro S; Tumino R; Panico S; Dollé M; Peeters PHM; Onland-Moret NC; Sandanger TM; Nøst TH; Weiderpass E; Quirós JR; Agudo A; Rodriguez-Barranco M; Huerta Castaño JM; Barricarte A; Fernández AM; Travis RC; Vineis P; Muller DC; Riboli E; Gunter M; Romieu I; Herceg Z
    Eur J Cancer; 2017 Apr; 75():299-307. PubMed ID: 28259012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using Illumina Infinium HumanMethylation 450K BeadChip to explore genome‑wide DNA methylation profiles in a human hepatocellular carcinoma cell line.
    Sun N; Zhang J; Zhang C; Shi Y; Zhao B; Jiao A; Chen B
    Mol Med Rep; 2018 Nov; 18(5):4446-4456. PubMed ID: 30221710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
    Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
    Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequent promoter hypermethylation of BRCA2, CDH13, MSH6, PAX5, PAX6 and WT1 in ductal carcinoma in situ and invasive breast cancer.
    Moelans CB; Verschuur-Maes AH; van Diest PJ
    J Pathol; 2011 Oct; 225(2):222-31. PubMed ID: 21710692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome-wide DNA methylation analysis reveals molecular subtypes of pancreatic cancer.
    Mishra NK; Guda C
    Oncotarget; 2017 Apr; 8(17):28990-29012. PubMed ID: 28423671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome-wide DNA methylation profile identified a unique set of differentially methylated immune genes in oral squamous cell carcinoma patients in India.
    Basu B; Chakraborty J; Chandra A; Katarkar A; Baldevbhai JRK; Dhar Chowdhury D; Ray JG; Chaudhuri K; Chatterjee R
    Clin Epigenetics; 2017; 9():13. PubMed ID: 28174608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HDAC5 Inhibitors as a Potential Treatment in Breast Cancer Affecting Very Young Women.
    Oltra SS; Cejalvo JM; Tormo E; Albanell M; Ferrer A; Nacher M; Bermejo B; Hernando C; Chirivella I; Alonso E; Burgués O; Peña-Chilet M; Eroles P; Lluch A; Ribas G; Martinez MT
    Cancers (Basel); 2020 Feb; 12(2):. PubMed ID: 32050699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring DNA methylation changes in promoter, intragenic, and intergenic regions as early and late events in breast cancer formation.
    Rauscher GH; Kresovich JK; Poulin M; Yan L; Macias V; Mahmoud AM; Al-Alem U; Kajdacsy-Balla A; Wiley EL; Tonetti D; Ehrlich M
    BMC Cancer; 2015 Oct; 15():816. PubMed ID: 26510686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenome-wide DNA methylation landscape of melanoma progression to brain metastasis reveals aberrations on homeobox D cluster associated with prognosis.
    Marzese DM; Scolyer RA; Huynh JL; Huang SK; Hirose H; Chong KK; Kiyohara E; Wang J; Kawas NP; Donovan NC; Hata K; Wilmott JS; Murali R; Buckland ME; Shivalingam B; Thompson JF; Morton DL; Kelly DF; Hoon DS
    Hum Mol Genet; 2014 Jan; 23(1):226-38. PubMed ID: 24014427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Normal breast tissue DNA methylation differences at regulatory elements are associated with the cancer risk factor age.
    Johnson KC; Houseman EA; King JE; Christensen BC
    Breast Cancer Res; 2017 Jul; 19(1):81. PubMed ID: 28693600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Agglomerative epigenetic aberrations are a common event in human breast cancer.
    Novak P; Jensen T; Oshiro MM; Watts GS; Kim CJ; Futscher BW
    Cancer Res; 2008 Oct; 68(20):8616-25. PubMed ID: 18922938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.